Filing Flows › Syra Health (SYRA) › Q2 2026
Syra Health (SYRA) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
Syra Health (SYRA) reported revenue of $2.4M for the second quarter 2026 (Q2 2026), +23% from a year earlier and +5% from the quarter before. Operating margin was 10.5%, net earnings $250K (10.5% of revenue).
Syra Health, Q2 2026: revenue $2.4M (+23% year over year), operating margin 10.5%, net earnings $250K, operating cash flow −$719K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.4M | +5% | +23% |
| Gross profit | $1.1M | +10% | +42% |
| Operating profit | $252K | +32% | — |
| Net earnings | $250K | +4% | — |
| Operating cash flow | −$719K | -153% | — |
What changed
Revenue was $2.4M in Q2 2026, up 23% year over year and up 5% from the previous quarter. Population Health was the largest line at 72% of revenue. Healthcare Workforce added $316K year over year (up 87%), 70% of the total change.
Gross margin was 44.5%, up 5.8 points from Q2 2025. Operating profit was $252K, a 10.5% margin (up 13.8 points year over year). Operating expenses fell 0% while revenue rose 23%. The fastest-growing cost line was Research & development (+59%). Net earnings were $250K. The effective tax rate was 0.0%.
Operating cash flow was −$719K. Non-cash charges added back $1K of depreciation and $21K of share-based compensation. Working capital and other items used $1.0M.
Questions
What was Syra Health's revenue in the second quarter 2026?
Syra Health (SYRA) reported revenue of $2.4M for the second quarter 2026 (Q2 2026), +23% from a year earlier and +5% from the quarter before.
Was Syra Health profitable in the second quarter 2026?
Operating profit was $252K (10.5% of revenue) and net earnings $250K.
Source: Syra Health 10-Q on SEC EDGAR.